<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV)-induced diseases of males with <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> (XLP) include <z:e sem="disease" ids="C1264624" disease_type="Disease or Syndrome" abbrv="">fatal infectious mononucleosis</z:e> (IM), non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ML), <z:hpo ids='HP_0004432'>agammaglobulinemia</z:hpo>, and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>These phenotypes also occur as <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases in families, and EBV seronegative males in these families must be considered at risk for XLP until they seroconvert normally to EBV </plain></SENT>
<SENT sid="2" pm="."><plain>Given that 50% of males inheriting the defective XLP gene die following primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e>, it is vital that they be identified pre-<z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report results using molecular genetic techniques to provide information as to the relative risks of EBV negative males and potential carrier females in ten families wherein a single male had died of IM </plain></SENT>
</text></document>